CBD Life Sciences Inc. (OTCMKTS:CBDL – Get Free Report) saw a large growth in short interest during the month of August. As of August 31st, there was short interest totaling 27,672 shares, a growth of ∞ from the August 15th total of 0 shares. Based on an average daily volume of 3,765,865 shares, the days-to-cover ratio is currently 0.0 days.
CBD Life Sciences Price Performance
CBDL stock opened at $0.00 on Tuesday. CBD Life Sciences has a 1 year low of $0.00 and a 1 year high of $0.00.
CBD Life Sciences Company Profile
CBD Life Sciences, Inc is a U.S.-based company focused on developing and commercializing cannabinoid‐enhanced products for the wellness and consumer healthcare markets. The company’s core strategy centers on leveraging plant-derived phytocannabinoids, along with complementary natural ingredients, to formulate a range of topical and ingestible offerings. CBD Life Sciences operates under an emerging‐brand model, seeking to position its products at the intersection of pharmaceutical‐grade quality and mainstream consumer appeal.
The company’s product portfolio includes broad‐spectrum hemp-derived topical creams, gels and balms designed for localized relief, as well as oral formulations such as capsules, tinctures and soft gels aimed at general wellness support.
See Also
- Five stocks we like better than CBD Life Sciences
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
Receive News & Ratings for CBD Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CBD Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
